Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #34995 on Cel Sci Corporation (CVM)
lightrock
01/24/21 1:40 PM
#34996 RE: GD #34995
Primary Outcome Measures : Overall Survival (OS) in LI + CIZ + SOC vs. SOC [ Time Frame: 3 year ] OS will be assessed using Kaplan-Meier life-table and compared using a logrank test and confirmed further with tumor stage location and geographic stratified log rank tests. The unstratified logrank test constitutes the primary analysis. A two-sided p-value of 0.05 or less will be considered statistically significant for comparing the two groups. Interim analyses will be performed throughout the study to assess safety, sample size and futility.
01/24/21 3:19 PM
#34997 RE: GD #34995